STOCK TITAN

Johnson & Johnson to Participate in the Stifel 2024 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the Stifel 2024 Healthcare Conference on Monday, November 18th, at the Lotte New York Palace in New York. Michael Bodner, Group President, Heart Recovery & Circulatory Restoration, will represent the Company in a session scheduled at 10:55 a.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48 hours after the webcast.

Media:

media-relations@its.jnj.com

Investor:

investor-relations@its.jnj.com

Source: Johnson & Johnson

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

375.64B
2.40B
0.06%
73.56%
0.96%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NEW BRUNSWICK